Introduction
Despite the availability of chemical and molecular targeted drugs, almost 80% of patients with colorectal cancer in China rely on traditional Chinese medicine therapy. A number of studies have been performed recently to assess the therapeutic efficacy and safety of traditional Chinese medicine for treating cancer. 1, 2 It is noteworthy that gambogic acid, a major ingredient isolated from the Chinese herb Gamboge hanburyi, can not only inhibit cell growth, induce apoptosis, and arrest the cell cycle in various carcinoma cell lines, including pulmonary carcinoma, 3 hepatocellular carcinoma, 4 breast cancer, 5 prostate cancer, 6 and gastric cancer, 7 but it can also inhibit tumor cell proliferation and inhibit angiogenesis by suppressing the phosphorylation of Akt, Erk, c-Src, Fak, and vascular endothelial growth factor receptor 2. 8, 9 These findings suggest that gambogic acid may indeed be an effective agent in the treatment of cancer. However, to date, the potential mechanisms that account for the beneficial effects of gambogic acid remain largely unknown.
Recently, magnetic nanoparticles containing Fe 3 O 4 , which have excellent biocompatibility 10 and improved intracellular penetration, 11, 12 have become a focus for potential application in human medicine, including the delivery of anticancer drugs to overcome drug resistance and enhance the effectiveness of chemotherapy. 12, 13 Accumulating research has shown that not only can a combination of magnetic nanoparticles containing Fe 3 O 4 and adriamycin have a significant cytotoxic effect on drug-resistant K562/ A02 leukemia cells, 14, 15 but also that a combination of magnetic nanoparticles containing Fe 3 O 4 and antitumor drugs may interact synergistically to induce apoptosis in cancer cells. Further, it has been shown that the cytotoxicity and apoptosis induced by gambogic acid in cancer cells can be dramatically enhanced if gambogic acid is combined with magnetic nanoparticles containing Fe 3 O 4 , 16 but the signal transduction pathways accounting for the beneficial effects of gambogic acid remain largely unknown.
It is well known that apoptosis is a major mechanism of cell death. The phosphatidylinositol 3-kinase (PI3K/ Akt) pathway acts as a critical regulator of cell survival by stimulating cell proliferation and inhibiting apoptosis, and abnormal signal transduction pathways are important in tumorigenesis and tumor progression. 17 Bad, a member of the Bcl-2 family, is one of several substrates for Akt. 18 Phosphorylation of Bad by Akt suppresses its auxo-apoptotic functions, accounting in part for the potent survival function of Akt. 18 Close attention has been paid to identify new target drugs that block signal transduction pathways in cancer cells. 19 Overexpression of PI3K/Akt pathway components, such as PI3K/p85α, Akt1, and Akt2, may contribute to the growth and progression of colorectal cancer. 20, 21 Therefore, it may be that a strategy of targeted inhibition in PI3K/Akt pathway components could increase sensitivity to chemotherapy and decrease the metastatic capacity of colorectal cancer cells. 19, [22] [23] [24] At present, there are many compounds that target PI3K (or Akt) progressing through clinical trials. However, to the best of our knowledge, there has been no study of the effect of magnetic nanoparticles containing a combination of gambogic acid and Fe 3 O 4 in the PI3K/Akt/ Bad pathway in colon cancer cells. Given the role of the PI3K/ Akt signaling pathway, our aim in these experiments was to investigate the effect of magnetic nanoparticles containing Fe 3 O 4 and gambogic acid on LOVO cells and the potential role of this signaling pathway in the treatment of human colon cancer.
Materials and methods

Main materials
Gambogic acid (Kanion Pharmaceutical Co, Ltd, Jiangsu, China) was dissolved in dimethyl sulfoxide (Sigma-Aldrich, St Louis, MO), stored at -20°C, and then diluted as needed in RPMI 1640 medium (Gibco/BRL, Carlsbad, CA). Methylthiazol tetrazolium (MTT) and propidium iodide were purchased from Sigma-Aldrich (St Louis, CA). Fe 3 O 4 magnetic nanoparticles (State Key Laboratory of Bioelectronics, Nanjing, China) were well distributed in RPMI 1640 medium containing 10% (v/v) heat-inactivated new-born calf serum (Sijiqing, Hangzhou, China) using an ultrasonic generator (Kudos SK3300HP, 53 kHz, maximum power 180 W, Kudos Ultraphonic Instrument Limited, Shanghai, China) to obtain a colloidal suspension of Fe 3 O 4 magnetic nanoparticles. Gambogic acid was conjugated with the magnetic nanoparticles containing Fe 3 O 4 by mechanical absorption polymerization at 4°C for 48 hours, 16 and their size was approximately 50 nm. 4, 6-diamidino-2-phenylindole (DAPI) was obtained from Santa Cruz Biotechnology Inc (Santa Cruz, CA). An Annexin V-fluorescein isothiocyanate kit was obtained from Nanjing Keygen Biotech Co, Ltd (Nanjing, China), and Trizol reagent was from Invitrogen Life Technologies (Carlsbad, CA). Monoclonal antibodies of PI3K, p-PI3K, Akt, p-Akt, Bad, p-Bad, cytochrome c, caspase 9, caspase 3, and β-actin were from Santa Cruz Biotechnology Inc.
Cell culture
A human colorectal cancer cell line (LOVO) purchased from Nanjing Keygen Biotech Co, Ltd was cultured in RPMI 1640 medium containing 10% (v/v) heat-inactivated new-born calf serum, penicillin G 100 U/mL, and streptomycin 100 µg/ mL at 37°C in a humidified environment containing 5% CO 2 . 
Cell proliferation assay
Assessment of cell morphology
For assessment of cell morphology, LOVO cells were incubated for 48 hours as described earlier. The cells were then collected and stained with Wright's stain to observe the morphological changes in cells undergoing apoptosis by optical microscopy. Meanwhile, cells on other slides were fixed with methanol for 15 minutes, stained with DAPI fluorochrome dye, and then observed under a fluorescence microscope (I × 51; Olympus, Tokyo, Japan) with a peak excitation wave length of 340 nm.
Reverse transcriptase PCR assay
As described for the apoptosis assay, the treated LOVO cells were harvested and their total RNA content was then isolated using Trizol reagent according to the manufacturer's protocol. The reverse transcription reactions were performed using SuperScript™ II reverse transcriptase, and the newly synthetic cDNA was amplified within target and control sequences (Table 1) . Polymerase chain reaction (PCR) products were separated on 1% agarose gel and visualized with ethidium bromide staining using a Molecular Imager Gel Doc XR system (Bio-Rad, CA, USA), and quantified using Molecular Analyst software version 1.5 (Bio-Rad), with β-actin as an internal control for all genes. The relative value was calculated as the ratio of each group and the internal control group. The results are expressed as the mean value of three individual experiments.
Western blot assay
Western blot analysis was performed to examine the expression of PI3K, p-PI3K, Akt, p-Akt, Bad, p-Bad, cytochrome c, pro-caspase 9, caspase 9, pro-caspase 3, and caspase 3. In brief, total protein was isolated on ice and subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis using modified radioimmunoprecipitation assay buffer, and then transferred to a polyvinylidene difluoride membrane (65421, Pall Corporation, Port Washington, NY). The membrane was blocked with buffer containing 10% fat-free dry milk and performed with 1:200 dilution of monoclonal antibodies against either antihuman PI3K, p-PI3K, Akt, p-Akt, Bad, p-Bad, cytochrome c, pro-caspase 9, caspase 9, pro-caspase 3, caspase 3, or β-actin antibody, and then subsequently incubated with horseradish peroxidase-conjugated goat antirabbit (1:5000) as a secondary antibody. The band was detected using an enhanced chemiluminescence detection system (Amersham, Buckinghamshire, UK). Each value is presented as the relative density of protein bands normalized to β-actin.
Statistical analysis
All data are expressed as the mean ± standard deviation from triplicate experiments and analyzed using the statistical Package for Social Science (SPSS Release 13.0, IBM, Chicago, IL). The statistical significance of differences was determined by the Student's t-test in two groups and one-way analysis of variance among multiple groups. A P value , 0.05 was considered to be statistically significant.
Results
Inhibition of cell growth
Inhibition of LOVO cell growth was markedly lower when the concentration of gambogic acid was less than 0.35 µmol/L ( Figure 1A) ; however, the inhibition rate was increased in a dose-dependent and time-dependent manner when the dosage of gambogic acid was more than 0.35 µmol/L, suggesting that the minimum inhibition rate of gambogic acid was 0.35 µmol/L. Further, it was observed that addition of magnetic nanoparticles containing Fe 3 O 4 enhanced the inhibition of LOVO cells by gambogic acid, and 50% inhibition achieved by gambogic acid was reduced from 0.60 µmol/L to 0.41 µmol/L by 60 µg/mL magnetic nanoparticles containing a combination of Fe 3 O 4 and gambogic acid (P , 0.05, Figure 1B ), suggesting that this combination had a synergistic effect on apoptosis of LOVO cells.
Synergistic effect on apoptosis of LOVO cells
The data show that the proportion of apoptotic cells was higher in the gambogic acid group than that in the control group (20.12% ± 2.32% versus 9.04% ± 2.16%, P , 0. (Figure 2 ). 
Morphological changes in LOVO cells
Expression of apoptosis-related proteins by Western blot assay
Based on computer-assisted image analysis, it seems that apoptosis-related proteins in LOVO cells treated with 60 µg/mL Fe 3 O 4 magnetic nanoparticles showed no significant changes when compared with the control group (P . 0.05). However, cytochrome c, caspase 3, and caspase 9 protein levels in LOVO cells treated with 0.35 µmol/L gambogic acid increased dramatically when compared with the control group (P , 0.05, Figure 6 ), and upregulation was enhanced by the magnetic nanoparticles containing Fe 3 O 4 (P , 0.05). Conversely, compared with the control group, p-PI3K, p-Akt, p-Bad, pro-caspase 9, and pro-caspase 3 protein expression in LOVO cells treated with magnetic nanoparticles containing Fe 3 O 4 and gambogic acid was lower than that in cells treated with 0.35 µmol/L gambogic acid alone (P , 0.05, Figure 6 ), but there were no significant differences in levels of nonactivated proteins, including PI3K, Akt, and Bad in these four groups (P . 0.05, Figure 6 ).
Discussion
The ultimate goal of medical cancer research is to be able to manipulate the machinery of cell death. Regulation of Previous studies 25, 26 have shown that gambogic acid can induce apoptosis via alteration of different molecules associated with apoptosis, such as Bax/Bcl-2 and nuclear factor-κB. Recently, the synergistic effects of magnetic nanoparticles containing Fe 3 O 4 and gambogic acid in the apoptosis of leukemia cells were demonstrated. 16 Accumulating research findings have shown that nanotechnology and nanoparticles are becoming a focus for application in clinical medicine because of their stable biomolecular absorption, high surface energy, and small size comparable with biomolecules. 27, 28 Our present study shows that gambogic acid can inhibit Figure 1B) , indicating that magnetic nanoparticles containing Fe 3 O 4 themselves had no cytotoxicity, which is consistent with current research. 29 Our study also provides evidence that the apoptosis ratio in LOVO cells treated with an optimal combination of gambogic acid and Fe 3 O 4 magnetic nanoparticles increased dramatically compared with cells treated with gambogic acid alone (P , 0.05, Figure 2 ), which confirms that magnetic nanoparticles containing Fe 3 O 4 and gambogic acid have a synergistic effect on LOVO cells. At the same time, under optical microscopy ( Figure 3 ) and fluorescence microscopy (Figure 4) , typical features of apoptosis, including chromatin condensation, pyknosis of the nucleolus, and apoptotic bodies, were observed when LOVO cells were treated using gambogic acid with or without magnetic nanoparticles containing Fe 3 O 4 for 48 hours. Of note, the proportion of apoptotic cells in the gambogic acid group was less than that in the group receiving magnetic nanoparticles containing Fe 3 O 4 and gambogic acid.
However, no cell morphology typical of apoptosis was seen in either the group receiving magnetic nanoparticles containing Fe 3 O 4 or in the control group, and this result was confirmed by flow cytometry (Figure 2) .
In order to explore the potential mechanisms of action of gambogic acid, we investigated the status of the PI3K/ Akt signaling pathway, components of which are often overexpressed in colorectal cancer and play important roles in the growth and progression of the disease. 20, 21 An earlier study demonstrated that 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride and wortmannin, both known PI3K inhibitors, showed antitumorigenic activity in human colon cancer cells in vivo and could cause induction of apoptosis and cell growth arrest in several colorectal cancer cell lines. 30, 31 Our present data show that treatment with gambogic acid markedly inhibited the activity of PI3K at the transcriptional and translation levels, and that the mRNA of PI3K and the protein of the activated form of PI3K were substantially reduced (Figures 5 and 6 ). These variations were more significant when combined with magnetic nanoparticles containing Fe 3 O 4 . Nevertheless, differences between the Fe 3 O 4 magnetic nanoparticle and control groups were not found. It is well known that protein translation follows gene transcription, but mRNA and protein were detected simultaneously in our study, and this may explain why no obvious changes were found in total PI3K protein, although the mRNA and activated protein for PI3K were changed. This phenomenon was also found in later indices, including expression of Akt and Bad proteins.
As previously reported, Akt is the best known downstream target of PI3K, which binds PIP 3 at the plasma membrane, and this leads to phosphorylation of Akt at Ser-473 in its regulatory domain. 32 It has also been reported that inactivation of PI3K inhibits phosphorylation of Akt. 33 Consistent with prior research, our study revealed that downregulation of Akt mRNA and the p-Akt (Ser-473) protein was accompanied by inactivation of PI3K in LOVO cells treated with gambogic acid alone. Furthermore, inhibition of Akt was markedly enhanced when combined with magnetic nanoparticles containing Fe 3 O 4 (P , 0.05, Figures 5 and 6 ). Liu et al 34 reported recently that Akt, as a hinge in the signal transduction pathway, can regulate cell proliferation, apoptosis, and the cell cycle via a number of downstream molecules. It is worthwhile noting that it could directly or indirectly regulate apoptosis through the mitochondrial pathway. Bad is the first member of the Bcl-2 family found to be a substrate of Akt, and nonphosphorylated Bad is an activated state. It could be phosphorylated at Ser-136 by activation and phosphorylation 
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of Akt, 35 then separated from the heterodimer of Bcl-2/ Bcl-xL, bound to 14-3-3 scaffold proteins, and localized in the cytoplasm in an inactive form, thus playing an antiapoptotic effect. 36 Kim et al showed that phosphorylated Bad was increased in colorectal cancer cells, which may alter regulation of cell death during colorectal tumorigenesis. 37 Therefore, inhibition of Bad phosphorylation could be a promising way of treating or preventing colorectal cancer. To elucidate whether apoptosis induced by gambogic acid was through the mitochondrial pathway associated with the PI3K/ Akt/Bad signal transduction pathway, we then explored the status of Bad and its downstream molecules in LOVO cells. Our present study demonstrated that gambogic acid markedly reduced Bad mRNA and inhibited phosphorylation of Bad, especially its protein ( Figure 6 ). Moreover, the literature reports that overexpression of phospho-Akt correlates with phosphorylation of epithelial growth factor receptor, FKHR, and Bad in nasopharyngeal carcinoma. 38 Thus, we infer that 
these variations would be the result of the Akt signal being abrogated by gambogic acid. The crucial step in induction of apoptosis of dephosphorylated Bad requires release of cytochrome c into the cytoplasm, which provokes an apoptotic cascade. 39 In our study, it was found that levels of cytochrome c, mRNA, and protein were notably increased along with the decrease of phosphorylated Bad. Most notably, these variations in the group treated with magnetic nanoparticles containing Fe 3 O 4 and gambogic acid were more conspicuous than those in the group treated with gambogic acid alone. It has been shown that cytochrome c catalyzes oligomerization of apoptotic protease activating factor-1, which recruits and promotes activation of pro-caspase 9. 39 This, in turn, cleaves and activates the effector caspase 3, leading to apoptosis. 39 Our data show that, when accompanied by activation of cytochrome c, the activator caspase 9 and the executor caspase 3 are also activated, along with upregulation of the mRNAs for caspase 9 and caspase 3, and the proteins of cleaved caspase 9 and cleaved caspase 3 are detected. It is noteworthy that levels of mRNA and proteins for caspase 9 and caspase 3 in the group treated with a combination of magnetic nanoparticles containing Fe 3 O 4 and gambogic acid were higher than those in the group treated with gambogic acid alone, which confirms further that gambogic acid and magnetic nanoparticles containing Fe 3 O 4 have a synergistic effect on LOVO cells.
In light of the present data and previous findings, we believe that gambogic acid can stop PI3K transmitting a mitogenic signal to Akt, followed by activation of Bad, leading to release of cytochrome c and activation of caspase 9 and caspase 3. These events may be responsible for the apoptosis shown in Figure 7 . Notably, these effects are potentiated by the combination of Fe 3 O 4 magnetic nanoparticles and gambogic acid.
Conclusion
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